Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjustment Retained Earnings
Balance at beginning of period at Oct. 31, 2018	$ 668,916	$ 105,601	$ 587,252	$ (23,937)	$ 864	$ 864
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(47,930)		(47,930)
Issuance of shares for stock options exercised and restricted stock units vested	23,004	1,225	21,779
Stock-based compensation expense	7,025		7,025
Contribution of stock to a deferred compensation trust	1,404		1,404
Purchase of common stock	(21,937)	(392)	(21,545)
Other comprehensive loss	(1,179)			(1,179)
Net earnings	175,110		175,110
Balance at end of period at May. 03, 2019	805,277	106,434	723,959	(25,116)
Balance at beginning of period at Feb. 01, 2019	694,397	105,747	613,165	(24,515)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(24,007)		(24,007)
Issuance of shares for stock options exercised and restricted stock units vested	16,839	687	16,152
Stock-based compensation expense	3,101		3,101
Purchase of common stock	(22)		(22)
Other comprehensive loss	(601)			(601)
Net earnings	115,570		115,570
Balance at end of period at May. 03, 2019	805,277	106,434	723,959	(25,116)
Balance at beginning of period at Oct. 31, 2019	859,578	106,742	784,885	(32,049)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(53,744)		(53,744)
Issuance of shares for stock options exercised and restricted stock units vested	5,779	389	5,390
Stock-based compensation expense	5,367		5,367
Contribution of stock to a deferred compensation trust	2,568		2,568
Purchase of common stock	(1,482)	(20)	(1,462)
Other comprehensive loss	(1,653)			(1,653)
Net earnings	168,537		168,537
Balance at end of period at May. 01, 2020	984,950	107,111	911,541	(33,702)
Balance at beginning of period at Jan. 31, 2020	912,050	106,977	837,194	(32,121)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(26,888)		(26,888)
Issuance of shares for stock options exercised and restricted stock units vested	1,637	136	1,501
Stock-based compensation expense	1,407		1,407
Purchase of common stock	(121)	(2)	(119)
Other comprehensive loss	(1,581)			(1,581)
Net earnings	98,446		98,446
Balance at end of period at May. 01, 2020	$ 984,950	$ 107,111	$ 911,541	$ (33,702)